COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,755 Articles (22,943 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 3176: Articles 31751-31755

Novel ionophores active against La Crosse virus identified through rapid antiviral screening
Sandler, Z. J., Vu, M. N., Menachery, V. D., Mounce, B. C.
10.1101/2020.01.21.914929 — Posted: 2020-01-23
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
Shi, Z.-L., Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., Zheng, X.-S., Zhao, K., Chen, Q.-J., Deng, F., Liu, L.-L., Yan, B., Zhan, F.-X., Wang, Y.-Y., Xiao, G.
10.1101/2020.01.22.914952 — Posted: 2020-01-23 Discussion: Onsite
Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV
Letko, M. C., Munster, V.
10.1101/2020.01.22.915660 — Posted: 2020-01-22 Discussion: Onsite | Offsite
Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China
Dong, N., Yang, X., Chen, K., Chan, E., Yang, M., Chen, S.
10.1101/2020.01.20.913368 — Posted: 2020-01-21 Discussion: Onsite
A mathematical model for simulating the transmission of Wuhan novel Coronavirus
Chen, T., Rui, J., Wang, Q., Zhao, Z., Cui, J.-A., Yin, L.
10.1101/2020.01.19.911669 — Posted: 2020-01-19 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).